https://pharmatimes.com/news/acesion-pharma-launches-phase-2-trial-of-ap31969-in-atrial-fibrillation/

Acesion Pharma Initiates Phase 2 Clinical Trial of AP31969 for Treatment of Atrial Fibrillation